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Abstract
Reconsolidation is a process in which re-exposure to a reminder causes a previously
acquired memory to undergo a process of destabilisation followed by subsequent restabili-
sation. Different molecular mechanisms have been postulated for destabilisation in the
amygdala and hippocampus, including CB1 receptor activation, protein degradation and
AMPA receptor exchange; however, most of the amygdala studies have used pre-reexpo-
sure interventions, while those in the hippocampus have usually performed them after reex-
posure. To test whether the temporal window for destabilisation is similar across both
structures, we trained Lister Hooded rats in a contextual fear conditioning task, and 1 day
later performed memory reexposure followed by injection of either the NMDA antagonist
MK-801 (0.1 mg/kg) or saline in order to block reconsolidation. In parallel, we also performed
local injections of either the CB1 antagonist SR141716A or its vehicle in the hippocampus or
in the amygdala, either immediately before or immediately after reactivation. Infusion of
SR141716A in the hippocampus prevented the reconsolidation-blocking effect of MK-801
when performed after reexposure, but not before it. In the amygdala, meanwhile, pre-reex-
posure infusions of SR141716A impaired reconsolidation blockade by MK-801, although
the time-dependency of this effect was not as clear as in the hippocampus. Our results sug-
gest the temporal windows for CB1-receptor-mediated memory destabilisation during
reconsolidation vary between brain structures. Whether this reflects different time windows
for engagement of these structures or different roles played by CB1 receptors in destabilisa-
tion across structures remains an open question for future studies.
Introduction
Memory reconsolidation is a core process in the maintenance and updating of long-term
memories [1]. Reexposure to reminders reactivates previously learned memories, which may
lead not only to their behavioural expression but also to reconsolidation [2]. As reconsolida-
tion depends upon neurochemical and cellular mechanisms of synaptic plasticity, such as
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NMDA receptor activation [3] and protein synthesis [4], pharmacological treatment around
the time of memory reactivation can disrupt reconsolidation and result in subsequent
amnesia.
Importantly, memory reactivation does not necessarily trigger reconsolidation [5]. Instead
there is a necessity for synaptic destabilisation, which has been shown to be dissociable from
behavioural expression of the memory [6–8]. Activation of GluN2B-containing NMDA recep-
tors in the basolateral amygdala (BLA) was required for the destabilisation of auditory cued
fear memories, whereas antagonism of AMPA or GluN2A-containing NMDA receptors selec-
tively disrupted expression of the cued fear [6, 7]. Beyond NMDA receptor activation, other
proposed neurochemical mechanisms of memory destabilisation in the BLA include dopamine
receptors [9], cellular processes such as AMPA receptor subunit exchange [10], synaptic pro-
tein degradation [11, 12] and autophagy [12], and enzymes such as calcineurin [13], PP1 [14]
and CaMKII [15] (Table 1).
The requirement of NR2B activation, AMPA receptor endocytosis and proteasome-medi-
ated protein degradation recapitulate findings also observed in hippocampal contextual fear
memory destabilisation [16, 17], suggesting that there are common mechanisms of memory
destabilisation across neural loci. Other mechanisms proposed to mediate destabilisation in
the hippocampus include activation of CB1 receptors and L-type-voltage-dependent calcium
channels (LVGCCs) [18, 19] (Table 2). Given that contextual fear conditioning relies critically
upon both the dorsal hippocampus (DH) and the BLA [20, 21], synaptic destabilisation is likely
to occur in both loci, putatively acting upon local plasticity mechanisms that are activated dur-
ing memory reactivation.
The temporal requirement for destabilisation mechanisms in both structures, however, has
not been extensively explored. Initially, it was shown that infusion of the GluN2B receptor
antagonist ifenprodil into the BLA successfully disrupted memory destabilisation only when
performed pre-reactivation [6]. Pre-reactivation infusions have been the norm in exploring
destabilisation mechanisms is the amygdala (Table 1), with only a handful of studies describing
destabilisation-blocking effects of drugs injected post-reactivation–in this case, targeting intra-
cellular processes such as protein degradation [11, 13] and CaMKII activation [15].
On the contrary, most observations of destabilisation-blocking effects in the hippocampus
have been observed with post-training interventions, including protein degradation inhibitors
[16, 24–26] but also CB1 receptor antagonists and LVGCC blockers [19] (Table 2). The
involvement of neurotransmitter receptors at a later stage of the process than that observed in
the amygdala suggests that the temporal dynamics of destabilisation might differ between
these structures. However, this comparison is complicated by the fact that these studies dif-
fered not only in the locus of drug infusion, but also in the neurochemical target and the type
of fear conditioning assessed (i.e. cued vs contextual).
To address this question, we aimed to directly compare the effects of pre- and post-reactiva-
tion pharmacological interventions in the BLA and DH on the destabilisation of contextual
fear memory. As our established reconsolidation-blocking drug, MK-801 [4] is a non-competi-
tive NMDA receptor antagonist, we chose not to target GluN2B-related mechanisms, and
instead focussed on CB1 receptor involvement in destabilisation [27, 28].
Methods
Systematic review of the literature on destabilisation mechanisms
To review the literature summarised in Tables 1 and 2, we performed a PubMed search for
(“destabilization” OR “destabilisation” OR “labilization” OR “labilisation” OR "labile" OR "sta-
bility") AND (“reconsolidation” OR "retrieval" OR "recall" OR "reactivation") AND
Temporal and spatial dynamics of memory destabilisation
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("hippocampus" OR "amygdala" OR "hippocampal" OR "amygdalar" OR "BLA" OR "intrahip-
pocampal" OR "intraamygdala"). Our search yielded 166 articles, which were screened to select
those that studied the behavioural effects of a drug injected in the amygdala or hippocampus
on reconsolidation blockade caused by another intervention performed before or after mem-
ory reactivation. This led to the inclusion of 19 studies (with an additional study added manu-
ally), for which we extracted data regarding the structure, behavioural task, species, drugs and/
or interventions, injection timing and behavioural outcome (Tables 1 and 2).
Subjects
143 male Lister Hooded rats (275–325 g at the time of surgical preparation), were housed in
quads under a 12 h light/dark cycle (lights on at 0700) at 21˚C with food and water provided
ad libitum except during the behavioural sessions. Standard cages contained aspen chip bed-
ding and environmental enrichment was available in the form of a Plexiglass tunnel. Experi-
ments took place in a behavioural laboratory between 0830 and 1500. At the end of the
experiment, animals were humanely killed via a rising concentration of CO2; death was con-
firmed by cervical dislocation. All procedures were approved by a local ethical review commit-
tee (University of Birmingham Animal Welfare and Ethical Review Body) and conducted in
accordance to the United Kingdom Animals (Scientific Procedures) Act 1986, Amendment
Regulations 2012 (PPL P8B15DC34).
Surgical preparation
All rats were implanted with chronic indwelling stainless steel cannulae (Coopers Needle-
works, UK) under isoflurane anaesthesia and aseptic conditions according to our established
procedures [31]. 57 rats had cannulae targeting the DH [32] and the remaining 86 rats had
Table 2. Involvement of different molecular mechanisms in memory destabilisation before and after its reactivation in the hippocampus.
Timing Target Reference Task Species Drug Infusion Time Reconsolidation
Inhibitor
Outcome
Pre-
reexposure
mGluRs [28] CFC Rat 3HPG 10 min ACEA + Sulfasalazine No effect
Na+ channels [28] CFC Rat Tetrodotoxin 10 min ACEA + Sulfasalazine Blocks destabilisation
Dopamine
receptors
[29] OR Rat SCH23390 15 min Anisomycin/α-amanitin Blocks destabilisation
NMDA [30] CFC Rat Ifenprodil 15 min Distractor stimulus Blocks destabilisation
Post-
reexposure
UPS [24] CFC Rat β-lactacystin Immediately Anisomycin Blocks destabilisation and memory
enhancement
[16] CFC Mouse β-lactacystin Immediately Anisomycin Blocks destabilisation
[25] MWM Rat β-lactacystin Immediately Anisomycin Blocks destabilisation
[26] CFC Mouse MG132 Immediately Sulfasalazine Blocks destabilisation
CB1 [19] CFC Mouse SR14716A Immediately Anisomycin Blocks destabilisation
[18] MWM Mouse SR14716A Immediately Anisomycin Blocks destabilisation
LVGCCs [19] CFC Mouse Verapamil Immediately Anisomycin Blocks destabilisation
[18] MWM Mouse Verapamil Immediately Anisomycin Blocks destabilisation
Table shows the time of infusion, target molecule, reference, behavioural task, species, drugs used to block reconsolidation and destabilisation and behavioural outcome.
All reconsolidation and labilization blockers were injected in the hippocampus. α-amanitin, selective inhibitor of RNA polymerase II and III; 3HPG, (S)-
3-Hydroxyphenylglycine, mGluR1 agonist; ACEA, arachidonyl-2-chloroethylamide, CB1 agonist; CREB, cAMP response element-binding protein; LVGCCs, L-type
voltage-gated calcium channels; MG132, (N-[(phenylmethoxy)carbonyl]-L-leucyl-N-[(1S)-1-fromyl-3-methylbutyl]-L-leucinamide, proteasome inhibitor; MWM,
Morris Water Maze; OR, object recognition; SR14716A, rimonabant, CB1 antagonist; Sulfasalazine, IKappaB kinase inhibitor; Tetrodotoxin, sodium channel blocker;
Verapamil, L-type calcium channel inhibitor. Drugs and abbreviations not described here are shown in the legend to Table 1.
https://doi.org/10.1371/journal.pone.0205781.t002
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cannulae targeting the basolateral amygdala [33]. Cannula placements were verified by Nissl-
staining of sectioned drop-perfused brains. Rats were included in the data analysis if there was
histological evidence (glial scars) for the injector tip being located within the DH (including
CA1, DG & CA3) or BLA (including all subregions of the Lateral Amygdaloid Nucleus and
Basolateral Amygdaloid Nucleus). 9 rats were excluded from the DH groups, all on the basis of
histological assessment. 37 rats were excluded from the BLA groups; 15 could not be infused
bilaterally, and 22 were excluded on histological basis.
Drugs
MK-801 (Abcam, UK) was dissolved in sterile saline to a concentration of 0.1 mg/ml and was
administered i.p. at a dose of 0.1 mg/kg [27]. SR141716A (Tocris, UK) was dissolved in a vehi-
cle solution containing 3 drops (~100 μl) of Tween 80 in 2.5 mL of 7.5% dimethylsulphoxide
in PBS to a concentration of 8 μg/μl. Intracranial infusions were conducted using 28G cannu-
lae connected to an infusion pump by polyethylene tubing. 1.0 μl/side was infused into the DH
and 0.5 μl/side was infused into the BLA.
Behavioural equipment
The conditioning chambers (MedAssociates, VT) consisted of two identical illuminated boxes
(25 cm × 32 cm × 25.5 cm), placed within sound-attenuating chambers. The box walls were
constructed of steel, except by the ceiling and front wall, which were made of perspex. The
grid floor consisted of 19 stainless steel rods (4.8 mm diameter; 1.6 mm centre-to-centre), con-
nected to a shock generator and scrambler (MedAssociates, VT). Infrared video cameras were
mounted on the ceiling of the chambers (Viewpoint Life Sciences, France) and used to record
and quantify freezing behaviour automatically.
Behavioural procedures
Rats were conditioned and tested in pairs using previously-established behavioural parameters
[27]. In the conditioning session, they received 2 unsignalled footshocks (0.7 mA, 1.5-s), deliv-
ered 180 s and 211.5 s into a 273-s session. Two days later, they were returned to the condition-
ing chamber for a 5-min reactivation session. Rats were infused with SR141716A or vehicle
into the DH or BLA either immediately before or immediately after reactivation. They were
also injected i.p. with MK-801 or saline, either immediately after the reactivation session (for
the pre-reactivation infusion condition) or immediately after the post-reactivation infusion. 3
hours after reactivation, they were returned to the conditioning chamber for a 2-min post-
reactivation short-term memory (PR-STM) test. A further 2-min test was conducted 24 hr
after reactivation (post-reactivation long-term memory; PR-LTM). All test sessions were
video-recorded and automatically quantified for freezing behaviour using video tracking soft-
ware (Viewpoint Life Sciences, France).
Statistical analyses
% of time freezing during the test sessions was initially analysed with repeated measures 4-way
ANOVA in JASP 0.8.5.1 (JASP Team 2016) with Timing (pre- vs post-reactivation infusion),
Infusion (vehicle vs SR141716A), Injection (Saline vs MK-801), and Test (PR-STM vs
PR-LTM) as factors. Planned comparisons analysed the effects of Timing, Infusion and Injec-
tion at PR-LTM, PR-STM and Reactivation individually using 3-way ANOVA. Any significant
main effects or interactions within these 3-way ANOVAs were explored with analyses of sim-
ple main effects of the MK-801 injection (vs saline), with Timing and Infusion as moderators.
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PLOS ONE | https://doi.org/10.1371/journal.pone.0205781 January 15, 2019 5 / 16
This strategy allowed an analysis of whether MK-801 had amnestic effects at each test under
each sub-condition of SR141716A (or vehicle) infusion.
Statistical power to detect an effect size of d = 1 (estimated on the basis of our previous
work using MK-801 as a reconsolidation blocker [27] and compatible with average effect size
estimates generally obtained in fear conditioning experiments [34] was calculated using
G�Power 3.1.9.2. Estimated power for main effects was greater than 99% in 4-way ANOVA
and 92% in 3-way ANOVA. Interaction effects involving abolishment of this effect would be
thus powered at around 69% and 39%, respectively. Simple main effects analyses based on
individual groups, meanwhile, had a lower statistical power at 35%.
Results
Dorsal hippocampus
Fig 1 shows the results obtained with SR141716A infusions in the hippocampus. In the vehi-
cle-infused groups, systemic injections of MK-801 led to a decrease in freezing in comparison
to saline-injected controls in PR-LTM tests performed 24 h after reactivation, while no differ-
ences were observed in PR-STM tests. SR141716A infusion in the hippocampus abolished the
MK-801 effect when performed after reactivation, but had no effect when performed before it.
Analysis of conditioned freezing at PR-STM and PR-LTM tests revealed that the amnestic
effect of post-reactivation MK-801 upon contextual fear memory reconsolidation depended
upon the timing of intra-dorsal hippocampus infusion of SR141716A vs vehicle (Timing x
Infusion x Injection x Test: F(1,41) = 5.16, p = 0.028, η2p = 0.11). Planned comparisons showed
that, at PR-STM, there was no effect of infusion timing, SR141716A or MK-801 (Timing x
Infusion x Injection: F(1,41) = 0.57, p = 0.46, η2p = 0.01; Timing x Infusion: F(1,41) = 0.21,
p = 0.65, η2p = 0.005; Timing x Injection: F(1,41) = 0.013, p = 0.91, η
2
p = 0.000; Infusion x
Injection: F(1,41) = 0.16, p = 0.69, η2p = 0.004; Timing: F(1,41) = 1.97, p = 0.17, η
2
p = 0.05;
Infusion: F(1,41) = 0.59, p = 0.45, η2p = 0.01; Injection: F(1,41) = 1.33, p = 0.26, η
2
p = 0.03). In
contrast, at PR-LTM there was further evidence for a timing-dependent SR141716A modula-
tion of reconsolidation disruption by MK-801 (Timing x Infusion x Injection: F(1,41) = 5.19,
p = 0.028, η2p = 0.11; Timing x Infusion: F(1,41) = 1.06, p = 0.31, η
2
p = 0.03; Timing x Injec-
tion: F(1,41) = 2.67, p = 0.11, η2p = 0.06; Infusion x Injection: F(1,41) = 3.26, p = 0.08, η
2
p =
0.07; Timing: F(1,41) = 0.72, p = 0.40, η2p = 0.02; Infusion: F(1,41) = 1.22, p = 0.28, η
2
p = 0.03;
Injection: F(1,41) = 22.94, p<0.001, η2p = 0.36). Planned analyses of simple main effects of
Injection, with Timing and Infusion as moderators, confirmed that there were impairments in
freezing in MK-801-injected rats, compared to saline-injected controls, in both pre-reactiva-
tion infusion groups (Vehicle: p = 0.005; SR141716A: p = 0.001) and in the post-reactivation
vehicle infusion group (p = 0.001), but not in the post-reactivation SR141716A group
(P = 0.62). Therefore, SR141716A protected against the MK-801-induced impairment of
PR-LTM only when infused immediately after the reactivation session.
The effect at PR-LTM was not obviously due to differences in initial conditioning or differ-
ences between groups at the reactivation session (Table 3). Analysis of freezing at the reactiva-
tion session revealed an overall effect of pre-reactivation infusions to reduce freezing. (i.e. all
pre-reactivation groups [both saline and MK-801] vs all post-reactivation groups: F(1,41) =
4.87, p = 0.033, η2p = 0.11). Unlike for freezing at PR-LTM, there was no Timing x Infusion x
Injection interaction (F(1,41)<0.001, p = 0.98, η2p = 0.00).
Basolateral amygdala
Fig 2 shows the results obtained with SR141716A infusions in the amygdala. Once more, sys-
temic injections of MK-801 led to decreased freezing in PR-LTM tests in both vehicle-infused
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groups. Unlike in the hippocampus, however, SR141716A attenuated this effect when infused
pre-reactivation, and had no effect when infused after it. Once again, no differences were
observed in PR-STM tests.
Fig 1. SR141716A infusion into the dorsal hippocampus blocked the amnestic effect of MK-801 when SR141716A was infused immediately after, but not
before memory reactivation. MK-801 injection (0.1 mg/ml, i.p.) impaired freezing in the post-reactivation long-term memory test (PR-LTM) in rats infused
with vehicle prior to (A) or immediately after (B) memory reactivation. While pre-reactivation infusion of SR141716A (8 μg/μl) did not alter the amnestic effect
of MK-801 (C), post-reactivation SR141716A prevented the MK-801-induced impairment in freezing at PR-LTM (D). Statistical analyses confirmed a selective
effect in the post-reactivation SR141716A condition (Timing x Infusion x Injection: F(1,41) = 5.19, p = 0.028, η2p = 0.11). No effect of MK-801 injection or
SR141716A infusion was observed in the post-reactivation short-term memory test (PR-STM). Data are presented as individual units and mean. n = 6 for all
pre-reactivation groups, 6 for post-reactivation Saline, 5 for post-reactivation MK-801 and 7 for post-reactivation SR141716 + Saline and SR141716 + MK-801.
https://doi.org/10.1371/journal.pone.0205781.g001
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Analysis of conditioned freezing at PR-STM and PR-LTM tests revealed that the amnestic
effect of post-reactivation MK-801 upon contextual fear memory reconsolidation was not
obviously dependent upon the timing of SR141716A infusion (Timing x Infusion x Injection x
Test: F(1,41) = 0.009, p = 0.93, η2p = 0.00; Infusion x Injection x Test: F(1,41) = 0.32, p = 0.58,
η2p = 0.008; Injection x Test: F(1,41) = 11.04, p = 0.002, η
2
p = 0.21). Planned comparisons
showed that at PR-STM, there was no effect of infusion timing, SR141716A or MK-801 (Tim-
ing x Infusion x Injection: F(1,41) = 1.11, p = 0.30, η2p = 0.03; Timing x Infusion: F(1,41) =
0.60, p = 0.44, η2p = 0.01; Timing x Injection: F(1,41) = 0.15, p = 0.70, η
2
p = 0.004; Infusion x
Injection: F(1,41) = 0.075, p = 0.79, η2p = 0.002; Timing: F(1,41) = 0.88, p = 0.35, η
2
p = 0.02;
Infusion: F(1,41) = 0.50, p = 0.49, η2p = 0.02; Injection: F(1,41) = 0.42, p = 0.52, η
2
p = 0.02). In
contrast, at PR-LTM there was evidence for an amnestic effect of MK-801 (Injection: F(1,41) =
19.77, p<0.001, η2p = 0.33), although this was not clearly dependent upon SR141716A infusion
or timing (Infusion x Injection: F(1,41) = 0.78, p = 0.38, η2p = 0.002; Timing x Infusion x Injec-
tion: F(1,41) = 1.11, p = 0.30, η2p = 0.026). However, planned analyses of simple main effects
suggested impairments in freezing in MK-801-injected rats in both post-reactivation infusion
groups (Vehicle: p = 0.021; SR141716A: p = 0.023) and the pre-reactivation vehicle infusion
group (p = 0.006), but not in the pre-reactivation SR141716A group (p = 0.25). Therefore,
SR141716A appeared to protect against the MK-801-induced impairment of PR-LTM when
infused immediately before the reactivation session, although the dissociation between pre-
and post-reactivation effects was not as clear-cut as that observed in the hippocampus.
The effect at PR-LTM was again not obviously due to differences in initial conditioning or
differences between groups at the reactivation session (Table 3). Unlike for the DH, pre-reacti-
vation infusion did not acutely affect freezing at the reactivation session (F(1,40) = 0.27,
p = 0.61, η2p = 0.007). There was also no Timing x Infusion x Injection interaction (F(1,40) =
1.20, p = 0.28, η2p = 0.029), nor a main effect of MK-801 (F(1,40) = 0.003, p = 0.96, η
2
p = 0.00,
indicating that the main-effect of MK-801 on freezing at PR-LTM observed above does not
seem to be due to pre-existing differences between groups.
Table 3. Contextual freezing at the reactivation session.
Mean SEM
DH
Pre-reactivation Veh Sal 26.9 13.7
MK-801 23.2 12.1
SR Sal 14.6 6.0
MK-801 13.9 5.7
Post-reactivation Veh Sal 52.1 12.9
MK-801 41.6 12.6
SR Sal 38.6 5.7
MK-801 31.9 6.5
BLA
Pre-reactivation Veh Sal 32.1 4.1
MK-801 33.5 4.4
SR Sal 28.3 2.6
MK-801 37.0 10.1
Post-reactivation Veh Sal 36.7 3.7
MK-801 36.2 4.0
SR Sal 37.1 3.7
MK-801 28.3 3.7
https://doi.org/10.1371/journal.pone.0205781.t003
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Discussion
Our results show that post-reactivation systemic MK-801 injection disrupted subsequent con-
textual fear memory expression 24h (but not 3h) after reactivation. However, this memory
Fig 2. CB1 receptor antagonism in the basolateral amygdala impairs memory destabilization when performed before memory reactivation. MK-801
injection (0.1 mg/ml, i.p.) impaired memory reconsolidation in the long-term memory test (PR-LTM) in the groups infused with vehicle either before (A;
simple main effect of injection, p = 0.006) or immediately after (B; p = 0.023) memory reactivation. While pre-reactivation infusion of SR141716A (8 μg/μl)
seemed to prevent the amnestic effect of MK-801 (C; p = 0.25), post-reactivation infusion did not (D; p = 0.021. However, there was no significant interaction
between the timing of infusion and the effect of MK-801 (Timing x Infusion x Injection: F(1,41) = 1.11, p = 0.30, η2p = 0.026). No effect of MK-801 injection or
SR141716A infusion is observed in the short-memory test at 3h (PR-STM). Data are presented as individual units and mean. n = 6 per group, except for pre-
reactivation SR141716 + Saline, in which n = 7.
https://doi.org/10.1371/journal.pone.0205781.g002
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disruption was seemingly prevented when the CB1 receptor antagonist SR141716A was
infused into the BLA or DH. Importantly, SR141716A-mediated protection against amnesia
had different temporal windows of efficacy depending upon the locus of infusion. Pre-reacti-
vation infusions were only effective when targeted into the BLA, whereas only post-reactiva-
tion infusions in the dorsal hippocampus prevented MK-801-induced amnesia.
The disruption of contextual fear memory by MK-801 likely reflects an impairment of
memory reconsolidation. We and others have previously demonstrated that post-reactivation
treatment with NMDA receptor antagonists disrupts reconsolidation of various types of mem-
ory [13, 35–37]. The post-reactivation timepoint of drug treatment avoids acute effects on the
reactivation session itself, and the preservation of contextual fear memory expression at the
3-h post-reactivation PR-STM test, as expected for reconsolidation blockade [4], rules out
non-specific chronic effects of MK-801. While we did not include an operational non-reactiva-
tion control condition, the SR141716A-induced protection against the amnestic effect of MK-
801 shows that this effect is destabilisation-dependent, and thus likely dependent on reactiva-
tion. An alternative account of post-reactivation amnesia focussing on memory integration
has been recently proposed [38]. While such an account might explain the amnestic effect of
MK-801 alone, it is not clear how it would explain the observation that additional treatment
with local SR141716A, within specific differential time windows, reverses MK-801-induced
amnesia.
The prevention of MK-801-induced reconsolidation disruption by post-reactivation dorsal
hippocampal SR141716A replicates a previous study in mice that used intra-hippocampal ani-
somycin as the amnestic agent [19]. This pattern of results, with no effect of SR141716A on its
own on contextual fear memory (and no enhancement of contextual freezing that might offset
the disruptive effect of MK-801) has been interpreted as an impairment of memory destabilisa-
tion [6, 19, 39, 40], and is consistent with our recent observation that pharmacological agonism
of hippocampal CB1 receptors can stimulate the destabilisation of contextual fear memories
[28].
While CB1 receptors in the BLA have been studied relatively extensively in fear memory
and its extinction, the evidence is more limited when considering memory destabilisation/
reconsolidation of contextual fear memories. The CB1 receptor antagonist AM251 had no
effect on reconsolidation by itself, but prevented the enhancement of reconsolidation by CB1
receptor agonism in a fear-potentiated startle setting [41]. This was interpreted as a purely
pharmacological effect (i.e. the AM251-blockade of CB1 receptors directly preventing pharma-
cological agonism), although it is not inconsistent with a potential effect of CB1 receptor
antagonism in preventing memory destabilisation.
However, Ratano et al [42] observed that AM251, at a substantially lower dose (300 ng/side
c.f. 20 μg/side), did impair post-reactivation long-term memory. This effect was shown with
AM251 infusions immediately after, but not 30 min prior to, memory reactivation and
appeared to be mediated by the dysregulation of GABAergic signalling in the BLA [42]. This
contrasts with our observation that SR141716A had no effect alone when infused immediately
before or after reactivation. It remains unclear what accounts for this discrepancy, and what
are its implications for our interpretation of an intra-BLA SR141716A-mediated impairment
of contextual fear memory destabilisation. A difference in memory type (cued vs contextual
fear) exists, but may not be important, given that the BLA is hypothesised to have a conceptu-
ally similar role in both settings, associating the CS or contextual representation with the US
[43–45]. Another difference is the CB1 antagonist employed: while AM251 and SR141716A
are structurally similar, and both have “inverse cannabimimetic effects” consistent with phar-
macological inverse agonism [46], there is some evidence that the two drugs may differ in their
affinity for an unidentified central vanilloid VR1-like receptor [47].
Temporal and spatial dynamics of memory destabilisation
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Our BLA SR141716A results are not only potentially inconsistent with those of Ratano et al
[42], but less clear-cut statistically than our DH SR141716A results. The conclusion that intra-
BLA SR141716A disrupts contextual fear memory destabilisation only when infused prior to
memory reactivation results from planned analyses of simple main effects, and should be con-
sidered as preliminary in the absence of conclusive evidence for a dependence of MK-801
effects upon either the timing of the BLA infusion or its content (SR141716A vs vehicle). Nev-
ertheless, there is a clear difference between the BLA and DH results, with stronger evidence
for intra-dorsal hippocampal SR141716A having destabilisation-impairing effects only when
infused after reactivation. This temporal pattern is largely consistent with previous studies
using different destabilisation-inhibitors, with pre-reactivation selectivity in the BLA [3] and
post-reactivation sufficiency in the hippocampus [19, 46]. Our study adds to this picture the
fact that, in the hippocampus, the effects of destabilisation blockade by CB1 receptors seem to
be restricted to the post-reactivation period.
The fact that the intra-DH infusion of SR141716A immediately before reactivation did not
disrupt destabilisation might indicate a delayed temporal window of CB1 receptor necessity in
this structure. The short (5 min) duration of the reactivation session is such that the pharmaco-
logical action of SR141716A would likely have persisted into the immediate post-reactivation
period. Indeed behavioural evidence indicates that intracranial infusions of SR141716A have
acute effects lasting at least 15 min [48], which would certainly encompass both the reactiva-
tion session and at least the first part of the post-reactivation period. Alternatively, it is possible
that blocking CB1 receptors before reactivation engages other mechanisms in memory desta-
bilisation, whereas this does not occur when reactivation has already occurred. Similar
accounts of ‘optional’ engaging of the hippocampus have been observed for injections prior to
reactivation of remote memories [49], and although we have no clear mechanistic explanation
for this hypothesis, it should nevertheless be kept in mind.
The present evidence demonstrates different temporal windows of efficacy of destabilisa-
tion blockade between the amygdala and hippocampus when the same memory task, amnestic
agent and destabilisation inhibitor are used. Therefore, the differential effects are not likely to
be due to pharmacodynamics or pharmacokinetics of different drugs, nor to potential differ-
ences in the engagement of destabilisation mechanisms because of discrepant memory settings
and strength of conditioning. Moreover, analysis of freezing values in the reactivation session
(Table 3) suggests that they are not due to pre-existing differences between groups.
This opens up an interesting question concerning whether memory destabilisation during
reconsolidation represents a single, unified phenomenon, or whether distinct phenomena
involving CB1 receptors in different structures lead to a similar behavioural outcome of mem-
ory weakening when reconsolidation is blocked. As destabilisation shares common molecular
mechanisms across brain structures [3, 16, 50], it is possible that the different temporal profiles
of CB1 involvement reflect the distinct temporal dynamics of each structure’s role in fear con-
ditioning. In this view, destabilisation mechanisms are engaged at a later stage in the hippo-
campus, but are involved in plasticity processes that are similar to those in the amygdala, as
suggested by the common behavioural outcome of destabilisation blockade in both structures.
Such a view would allow for additional speculation about the downstream cellular mechanisms
of destabilization engaged by CB1 receptor activation. Given the functional link between CB1
receptor activation and both calcineurin [51] and protein degradation at the proteasome [52],
there is a likely functional pathway of memory destabilization that includes these mechanisms.
Against this view, however, is the fact that for other molecular mechanisms involved in
destabilisation, this temporal dissociation does not seem as clear. Blockade of both NR2B
receptors [6, 30] and D1 receptors [9, 29] has been shown to have effects on memory destabili-
sation when performed pre-reactivation in both the amygdala and the hippocampus. Similarly,
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interference with protein degradation by the proteasome is effective when performed post-
training in either structure. Although one should be careful when comparing effects in differ-
ent structures across different studies, as many other parameters might vary among them, this
finding suggests that the temporal dissociation we have observed might be a particular feature
of interventions targeted at the CB1 receptor.
A second possibility, thus, is that the mechanism through which CB1 receptor activation
leads to the behavioural outcome of memory destabilisation is different in both structures.
Although the pharmacological profile of destabilisation in the amygdala and in the hippocam-
pus is generally similar, some of the molecular mechanisms involved–which include CB1
receptors, the ubiquitin-proteasome system [19, 39] and AMPA receptor endocytosis [10, 17]
in both structures, L-type voltage-gated calcium channels in the hippocampus [19] and calci-
neurin in the amygdala [12]–are also involved in other forms of behavioural and synaptic plas-
ticity, such as memory extinction [1], normal forgetting [53] and homeostatic synaptic
downscaling [54, 55]. Thus, it is possible that the CB1 receptor might be part of a more general
plasticity system that is engaged in the amygdala and the hippocampus for different purposes
during memory updating.
Finally, another open question is how other functions of the CB1 receptor in the amygdala,
such as the mediation of different forms of memory extinction [56, 57] and acute fear relief
[58] relate to its role in memory destabilisation during contextual reexposure. It is interesting
to note that CB1 receptors seem to be particularly important for within-session freezing
decrease [59], a phenomenon that can temporally co-occur with memory labilization during
reexposure. Although no correlation has been shown between the degree of freezing decrease
during reexposure and the effect of post-reactivation injections of MK-801 [27], it is neverthe-
less possible that the decrease in fear during reexposure mediated by CB1 in the amygdala
could play a role in setting off labilization mechanisms, which might later mediate memory
updating in the hippocampus and other structures.
These and other matters, however, remain open to further studies, which might reveal
whether the temporal dissociation between labilization in the hippocampus and amygdala
observed with CB1 receptors occurs with other molecular targets as well. In the meantime, our
results show that memory destabilisation during reconsolidation of contextual fear condition-
ing is a complex process that cannot be pinpointed to a single structure or time point, and that
the temporal dynamics of the engagement of destabilisation mechanisms may differ between
brain structures.
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